01 7Nilemdo/Nustendi
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 22
2020 Revenue in Millions : 0
Growth (%) : 100
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 22
2020 Revenue in Millions : 0
Growth (%) : 100
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 45
2021 Revenue in Millions : 22
Growth (%) : 103
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 45
2021 Revenue in Millions : 22
Growth (%) : 103
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 45
2021 Revenue in Millions : 22
Growth (%) : 103
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2023 Revenue in Millions : 97
2022 Revenue in Millions : 45
Growth (%) : 147
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2023 Revenue in Millions : 97
2022 Revenue in Millions : 45
Growth (%) : 147
LOOKING FOR A SUPPLIER?